<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03767023</url>
  </required_header>
  <id_info>
    <org_study_id>H2014-3 AAA</org_study_id>
    <nct_id>NCT03767023</nct_id>
  </id_info>
  <brief_title>Clinical and Microbiological Relationships Between Periodontitis and Abdominal Aorta Aneurism: an Case Control Study</brief_title>
  <official_title>Clinical and Microbiological Relationships Between Periodontitis and Abdominal Aorta Aneurism: an Case Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aorta Abdominal aneurism (AAA) is a chronic degenerative disorder leading to the dilation and&#xD;
      eventually to the rupture of the aortic wall. The pathology presents risk factors such as&#xD;
      aging, atherosclerosis, male gender, cigarette smoking, pulmonary emphysema and high blood&#xD;
      pressure.The vascular wall destruction is characterized by a remodeling of the extracellular&#xD;
      matrix (ECM), the presence of an inflammatory infiltrate of macrophages and lymphocytes&#xD;
      associated increase in production of MMPs. A similar destruction mechanisms is found in&#xD;
      periodontitis a chronic inflammatory diseases characterized by gram-negative bacteria species&#xD;
      that are able to degrade ECM of the tooth supporting tissues and leading finally to tooth&#xD;
      loss .Moreover, relationships between periodontitis and cardiovascular disease have already&#xD;
      been demonstrated. These associations are considered to be initiated by transient or&#xD;
      prolonged bacteremia due to dissemination of oral bacteria or their products into the&#xD;
      bloodstream . The periopathogens, more specifically Porphyromonas gingivalis (Pg), were&#xD;
      observed in atherosclerosis and aneurysm specimens as well as in coronary heart disease and&#xD;
      endocarditis The association between periodontitis and Abdominal Aortic Aneurysms (AAA) has&#xD;
      not often been studied especially from a clinical aspect. The mechanisms that induce the&#xD;
      initiation, the development or the recurrence and the rupture of AAA after a period of&#xD;
      quiescence not well studied and are therefore still unknown.&#xD;
&#xD;
      The aim of this clinical observational case controlled study is to search for a possible&#xD;
      relationship between periodontal disease and rapid growth of AAA. Patients presenting stable&#xD;
      or unstable AAA will be screened for the degree of periodontitis, for the type of oral&#xD;
      microbiology and periodontopathogen markers present in the blood stream.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      31 consecutive dentulous patients diagnosed for AAA requiring a cardiovascular surgery&#xD;
      (instable AAA) and 31 consecutive dentulous patients with stable AAA (no need for&#xD;
      cardiovascular surgery) will be recruited from the Cardiovascular Surgery Department of the&#xD;
      University Hospital of Liège (Faculty of Medicine, University of Liège, Belgium - Pr. N.&#xD;
      Sakalihasan). The 62 patients will be subjected to:&#xD;
&#xD;
        1. Full clinical periodontal parameter assessment&#xD;
&#xD;
        2. Microbiological analyses of saliva,&#xD;
&#xD;
        3. Supra- and sub- gingival microbiological test&#xD;
&#xD;
        4. Blood test for biomarker analysis.&#xD;
&#xD;
        5. Imaging (echography, CT-Scans)measurments&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pocked depth correlated with AAA stability</measure>
    <time_frame>june 2017</time_frame>
    <description>Periodontal clinical parameters such as pocked depth (PD, millimeter) will be correlated with AAA stability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pocked depth correlated with abdominal aortic aneurysm diametres such as anterior -posterior</measure>
    <time_frame>March 2018</time_frame>
    <description>Periodontal clinical parameters such as pocked depth (PD, millimeter) will be correlated with abdominal aortic aneurysm diametres such as anterior -posterior (AP,millimeter)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">61</enrollment>
  <condition>Abdominal Aorta Aneurism</condition>
  <condition>Periodontitis</condition>
  <condition>Dentulous</condition>
  <arm_group>
    <arm_group_label>Stable AAA</arm_group_label>
    <description>= patients with a small abdominal aortic aneursym diameter &lt; 55 mm &quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>instable AAA</arm_group_label>
    <description>=patients with a large abdominal aortic aneursym diameter &gt; 55 mm and/or AAA with rapid growth who needs open surgery or EndoVascular Aneurysm Repair &quot;EVAR</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cross sectional</intervention_name>
    <arm_group_label>Stable AAA</arm_group_label>
    <arm_group_label>instable AAA</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva, sub-gingival and supra-gingival samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the Cardiovascular Surgery Department, University Hospital of Liège (Belgium)&#xD;
        and presenting AAA were screened in order to include 31 patients in each group (stable&#xD;
        versus instable AAA) according to the sample size calculation. Sixty-two patients were&#xD;
        therefore included according to the following inclusion and exclusion criteria:&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  AAA&#xD;
&#xD;
          -  dentulous&#xD;
&#xD;
          -  ability to come in Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diseases of connective tissue: rheumatoid arthritis, systemic lupus erythematosus,&#xD;
             systemic sclerodermia, Crohn disease, Marfan syndrome, Heler Danlos syndrome,&#xD;
             polymyosite/dermatomyosite, mix connectivite (MCDT)&#xD;
&#xD;
          -  aneurysms of the lower limbs (femoral or popliteal)&#xD;
&#xD;
          -  contraindication to the scanner&#xD;
&#xD;
          -  participation of another clinical trial 30 days before baseline&#xD;
&#xD;
          -  patient with risk oslerien&#xD;
&#xD;
          -  taking antibiotics during the 3 months preceding the inclusion&#xD;
&#xD;
          -  obese patients (BMI ≥ 30 kg/m2)&#xD;
&#xD;
          -  immunosuppressant drugs or chemotherapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>October 26, 2018</study_first_submitted>
  <study_first_submitted_qc>December 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2018</study_first_posted>
  <last_update_submitted>December 12, 2018</last_update_submitted>
  <last_update_submitted_qc>December 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Leila Salhi</investigator_full_name>
    <investigator_title>Doctor of Dental Surgery (DDS), Master of sciences (MS), PhD student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

